Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

[Regulatory Requirements and Considerations of Aesthetic Injection Medical Devices in China, the USA and the European Union].

PMID: 41672626 · 2026

JournalZhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation
Year2026
PMID41672626

Abstract

This study summarizes the marketing access and regulatory requirements of aesthetic injection medical devices in China, the USA, and the European Union (EU), and conducts a comparative analysis of the regulatory similarities and differences among these regions. There are differences in the supervision of aesthetic injection medical devices in China, the USA, and the EU, but they are essentially converging. It is recommended that Chinese medical device authorities improve the formulation of relev

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.